Cancer biotech raising $20m after delaying Nasdaq float
SYDNEY: Sydney-based biotech EnGeneIC is tapping investors to raise $20 million in bridging ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
